Literature DB >> 1503917

Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales.

M M Hawkins1, A J Swerdlow.   

Abstract

For the last 20 years the National Health Service Central Register (NHSCR) has been used as the principal source of follow-up for mortality, and often for cancer incidence, in many cohort and clinical follow-up studies in England and Wales. Completeness of notification of childhood cancer registrations and deaths from the NHSCR was investigated by comparison between cancers and deaths notified to the Childhood Cancer Research Group (CCRG) from this source and notifications received directly from regional cancer registries and the national death registry. Six thousand, seven hundred and seventy-six (91.8%) of 7,379 cancers incident 1971-84, and 588 (95.8%) of 614 deaths occurring 1953-88, were successfully notified. Failures in cancer notification occurred mainly between the regional cancer registries and the National Cancer Register (3.3%), and between the National Cancer Register and the NHSCR (3.0%). An additional 1.9% of cancer notifications failed between the NHSCR and the CCRG. Incompleteness of registration of childhood cancers by regional cancer registries was estimated to be 4.7%. A total of 12.5% of incident childhood cancers were not notified by NHSCR. Incompleteness of notification may be greater for adults, for whom registration and record linkage may be more difficult. Failures in death notifications occurred mostly because deaths entered on the NHSCR were not notified to the CCRG (3.3%). This incompleteness of notification needs to be taken into account in the interpretation of published studies and in the analysis of studies using NHSCR flagging. It also implies similar incompleteness in published national cancer survival data, which use the same system of flagging. Nevertheless it is a notable achievement that NHSCR has successfully monitored such a high proportion of a population of 50 million people, by entirely clerical procedures, for 40 years.

Entities:  

Mesh:

Year:  1992        PMID: 1503917      PMCID: PMC1977803          DOI: 10.1038/bjc.1992.279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Completeness of follow up in a cohort study of mortality using the United Kingdom National Health Service Central Registers and records held by the Department of Social Security.

Authors:  S C Darby; J A O'Hagan; G M Kendall; R Doll; T P Fell; C R Muirhead
Journal:  J Epidemiol Community Health       Date:  1991-03       Impact factor: 3.710

2.  Estimation of completeness of cancer registration.

Authors:  R T Benn; I Leck; U P Nwene
Journal:  Int J Epidemiol       Date:  1982-12       Impact factor: 7.196

3.  Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison.

Authors:  U Nwene; A Smith
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

4.  The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study.

Authors:  L Villard-Mackintosh; M P Coleman; M P Vessey
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

5.  The completeness of cancer registration in follow-up studies--a cautionary note.

Authors:  K Hunt; M P Coleman
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  5 in total
  17 in total

1.  How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales?

Authors:  H O Dickinson; J A Salotti; P J Birch; M M Reid; A Malcolm; L Parker
Journal:  J Epidemiol Community Health       Date:  2001-06       Impact factor: 3.710

2.  The statistical power of epidemiological studies analyzing the relationship between exposure to ionizing radiation and cancer, with special reference to childhood leukemia and natural background radiation.

Authors:  M P Little; R Wakeford; J H Lubin; G M Kendall
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

3.  Audit of ascertainment of deaths to children born in Cumbria, UK, 1950-89 through the NHS central register.

Authors:  H O Dickinson; L Parker; D Harris; B Botting; A Lawson
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

4.  Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry.

Authors:  D J Seddon; E M Williams
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Review of risk factors of secondary cancers among cancer survivors.

Authors:  Charlotte Demoor-Goldschmidt; Florent de Vathaire
Journal:  Br J Radiol       Date:  2018-09-12       Impact factor: 3.039

6.  Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.

Authors:  Michael E Jones; Flora E van Leeuwen; Wilhelmina E Hoogendoorn; Marian Je Mourits; Harry Hollema; Hester van Boven; Michael F Press; Leslie Bernstein; Anthony J Swerdlow
Journal:  Breast Cancer Res       Date:  2012-06-12       Impact factor: 6.466

7.  The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.

Authors:  M Harding; D Hole; C Gillis
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

8.  Incompleteness of oral cancer registration in south-east England, 1971-87.

Authors:  K A Warnakulasuriya; P Acworth; J Bell; N W Johnson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

9.  Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain.

Authors:  H C Jenkinson; M M Hawkins; C A Stiller; D L Winter; H B Marsden; M C G Stevens
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

10.  A study of soft tissue sarcomas after childhood cancer in Britain.

Authors:  H C Jenkinson; D L Winter; H B Marsden; M A Stovall; M C G Stevens; C A Stiller; M M Hawkins
Journal:  Br J Cancer       Date:  2007-07-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.